BROOKS Stock Overview
Manufactures and sells pharmaceuticals in India and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Brooks Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹81.15 |
52 Week High | ₹185.70 |
52 Week Low | ₹61.00 |
Beta | 1.38 |
1 Month Change | -20.52% |
3 Month Change | -31.86% |
1 Year Change | 32.17% |
3 Year Change | -20.75% |
5 Year Change | 60.53% |
Change since IPO | 1,148.46% |
Recent News & Updates
Recent updates
Would Brooks Laboratories (NSE:BROOKS) Be Better Off With Less Debt?
Sep 28Does Brooks Laboratories (NSE:BROOKS) Have A Healthy Balance Sheet?
Jun 10Estimating The Intrinsic Value Of Brooks Laboratories Limited (NSE:BROOKS)
Feb 22Is Brooks Laboratories (NSE:BROOKS) Using Too Much Debt?
Dec 08Is Brooks Laboratories (NSE:BROOKS) A Risky Investment?
Jul 07Here's Why Brooks Laboratories (NSE:BROOKS) Can Afford Some Debt
Jan 05Brooks Laboratories (NSE:BROOKS) Is Making Moderate Use Of Debt
Sep 22Shareholder Returns
BROOKS | IN Life Sciences | IN Market | |
---|---|---|---|
7D | -7.0% | 2.4% | -1.9% |
1Y | 32.2% | 15.9% | 41.0% |
Return vs Industry: BROOKS exceeded the Indian Life Sciences industry which returned 15.9% over the past year.
Return vs Market: BROOKS underperformed the Indian Market which returned 41% over the past year.
Price Volatility
BROOKS volatility | |
---|---|
BROOKS Average Weekly Movement | 7.7% |
Life Sciences Industry Average Movement | 5.6% |
Market Average Movement | 6.4% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: BROOKS's share price has been volatile over the past 3 months.
Volatility Over Time: BROOKS's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 296 | n/a | www.brookslabs.net |
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Brooks Laboratories Limited Fundamentals Summary
BROOKS fundamental statistics | |
---|---|
Market cap | ₹2.13b |
Earnings (TTM) | -₹195.92m |
Revenue (TTM) | ₹804.42m |
2.6x
P/S Ratio-10.9x
P/E RatioIs BROOKS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BROOKS income statement (TTM) | |
---|---|
Revenue | ₹804.42m |
Cost of Revenue | ₹566.09m |
Gross Profit | ₹238.33m |
Other Expenses | ₹434.25m |
Earnings | -₹195.92m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -7.46 |
Gross Margin | 29.63% |
Net Profit Margin | -24.36% |
Debt/Equity Ratio | 7.7% |
How did BROOKS perform over the long term?
See historical performance and comparison